Interlude

STUDY IDENTIFIER:

Interlude

CONDITION:

Moderate to Severe Mitral Regurgitation

CONTACT INFO:

Sara Olson, RN   |   sara.olson@allina.com   |   612-863-7601

DESCRIPTION:

The purpose of this study is to assess the safety and performance of the Caisson Interventional Transcatheter MitralValve Replacement (TMVR) system for the treatment of severe symptomatic MitralValve Regurgitation (MR). This study will provide initial information on the safety and performance of this system.

CRITERIA LIST/ QUALIFICATIONS:

 
  1. Severe mitral regurgitation
  2. NYHA Class II, III or IVa or heart failure
  3. High risk for cardiovascular surgery

INVESTIGATORS:

Mario Goessl, MD

SPONSORS:

Caisson

STATUS:

Open/Enrolling

Get More Information